
Brain Biomarkers Market by Product (Biomarker Analyzers, Biomarker Test Kits), Indication (Alzheimer's Disease, Huntington's Disease, MND & ALS), End-Users, Application - Global Forecast 2024-2030
Description
Brain Biomarkers Market by Product (Biomarker Analyzers, Biomarker Test Kits), Indication (Alzheimer's Disease, Huntington's Disease, MND & ALS), End-Users, Application - Global Forecast 2024-2030
The Brain Biomarkers Market size was estimated at USD 8.94 billion in 2023 and expected to reach USD 10.54 billion in 2024, at a CAGR 17.90% to reach USD 28.33 billion by 2030.
Global Brain Biomarkers Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Brain Biomarkers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Brain Biomarkers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Brain Biomarkers Market, highlighting leading vendors and their innovative profiles. These include Advanced Brain Monitoring, Inc, Biognosys AG, BrainScope Company, Inc., F. Hoffmann-La Roche AG, GE Healthcare, Johnson & Johnson, Lifesign LLC, Magstim EGI, Merck KGaA,, Natus Medical Inc., NeuroVista Corporation, Nexus-DX, PhenoSwitch Bioscience, Seimens Healthnineers, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Brain Biomarkers Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Biomarker Analyzers
Biomarker Test Kits
Indication
Alzheimer's Disease
Huntington's Disease
MND & ALS
Parkinson's Disease
Stroke
End-Users
Ambulatory Surgical Centers
Diagnostic Laboratories
Hospitals
Research Laboratories
Application
Diagnosis
Drug Discovery & Development
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Brain Biomarkers Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Brain Biomarkers Market?
3. What are the technology trends and regulatory frameworks in the Brain Biomarkers Market?
4. What is the market share of the leading vendors in the Brain Biomarkers Market?
5. Which modes and strategic moves are suitable for entering the Brain Biomarkers Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
185 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Brain Biomarkers Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Improved knowledge of neurologic diseases and R&D investment to treat growing geriatric population with brain disorder
- 5.1.1.2. Need for invasive brain tastings, effective drug development, faster diagnosis, and new treatment option
- 5.1.1.3. Detection and interpretation to support clinical decisions and patient interventions
- 5.1.2. Restraints
- 5.1.2.1. Lack of consumer awareness
- 5.1.3. Opportunities
- 5.1.3.1. Evolving biomarker data management platforms to support biomarker-guided drug development and translational research
- 5.1.3.2. Incorporation of detectable parameters with brain biomarkers to improve clinical decision making
- 5.1.4. Challenges
- 5.1.4.1. Complexity of neuroinflammation exacerbated by substantial biological heterogeneity
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Brain Biomarkers Market, by Product
- 6.1. Introduction
- 6.2. Biomarker Analyzers
- 6.3. Biomarker Test Kits
- 7. Brain Biomarkers Market, by Indication
- 7.1. Introduction
- 7.2. Alzheimer's Disease
- 7.3. Huntington's Disease
- 7.4. MND & ALS
- 7.5. Parkinson's Disease
- 7.6. Stroke
- 8. Brain Biomarkers Market, by End-Users
- 8.1. Introduction
- 8.2. Ambulatory Surgical Centers
- 8.3. Diagnostic Laboratories
- 8.4. Hospitals
- 8.5. Research Laboratories
- 9. Brain Biomarkers Market, by Application
- 9.1. Introduction
- 9.2. Diagnosis
- 9.3. Drug Discovery & Development
- 10. Americas Brain Biomarkers Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Brain Biomarkers Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Brain Biomarkers Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Advanced Brain Monitoring, Inc
- 14.1.2. Biognosys AG
- 14.1.3. BrainScope Company, Inc.
- 14.1.4. F. Hoffmann-La Roche AG
- 14.1.5. GE Healthcare
- 14.1.6. Johnson & Johnson
- 14.1.7. Lifesign LLC
- 14.1.8. Magstim EGI
- 14.1.9. Merck KGaA,
- 14.1.10. Natus Medical Inc.
- 14.1.11. NeuroVista Corporation
- 14.1.12. Nexus-DX
- 14.1.13. PhenoSwitch Bioscience
- 14.1.14. Seimens Healthnineers
- 14.1.15. Thermo Fisher Scientific Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. BRAIN BIOMARKERS MARKET RESEARCH PROCESS
- FIGURE 2. BRAIN BIOMARKERS MARKET SIZE, 2023 VS 2030
- FIGURE 3. BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. BRAIN BIOMARKERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. BRAIN BIOMARKERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. BRAIN BIOMARKERS MARKET DYNAMICS
- FIGURE 7. BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
- FIGURE 10. BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
- FIGURE 12. BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 14. BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. BRAIN BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. BRAIN BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.